Long-term immune response check after tetanus vaccine
Part of Infections clinical trials.
This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been in the earlier phase 3 trial of this tetanus vaccine (study CTP-TTVA-001).
- It must be at least 2.5 years since you finished your vaccine doses in that study.
- You cannot have had any other tetanus shots or tetanus medicines after that study.
- You must have completed the required blood test 30 days after your last vaccine in the earlier study.
- You need to be willing to provide ID and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.
This study tests an injection that may help prevent tetanus in people who have had a high-risk exposure, like a deep or dirty wound. It aims to see if the injection is safe and effective for protecting against tetanus.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study checks if a simple saliva test can detect tetanus protection, which could replace blood tests. It includes healthy children, young adults, pregnant women, and adults with certain health conditions.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.